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Hypocretin/orexin (HCRT) andmelanin concentrating hormone (MCH)
neuropeptides are exclusively produced by the lateral hypothalamus
and play important roles in sleep, metabolism, reward, and motiva-
tion. Loss of HCRT (ligands or receptors) causes the sleep disorder
narcolepsy with cataplexy in humans and in animal models. How
these neuropeptides are produced and involved in diverse functions
remain unknown. Here, we developed methods to sort and purify
HCRT and MCH neurons from the mouse late embryonic hypothal-
amus. RNA sequencing revealed key factors of fate determination for
HCRT (Peg3, Ahr1, Six6, Nr2f2, and Prrx1) and MCH (Lmx1, Gbx2, and
Peg3) neurons. Loss of Peg3 in mice significantly reduces HCRT and
MCH cell numbers, while knock-down of a Peg3 ortholog in zebrafish
completely abolishes their expression, resulting in a 2-fold increase in
sleep amount. We also found that loss of HCRT neurons in Hcrt-
ataxin-3mice results in a specific 50% decrease in another orexigenic
neuropeptide, QRFP, that might explain the metabolic syndrome in
narcolepsy. The transcriptome results were used to develop protocols
for the production of HCRT and MCH neurons from induced pluripo-
tent stem cells and ascorbic acid was found necessary for HCRT and
BMP7 for MCH cell differentiation. Our results provide a platform to
understand the development and expression of HCRT and MCH and
their multiple functions in health and disease.
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The lateral and posterior hypothalamus play a central role inthe regulation of food intake (1), vigilance states (2, 3), re-
ward, and motivation (4). Among major cell types of this region
are hypocretin/orexin- (HCRT) and melanin concentrating
hormone- (MCH) producing cells. These neuropeptides are not
colocalized but their cells are spatially intermingled (5).
HCRT and MCH neurons send projections throughout the
central nervous system (CNS) (6, 7) and orchestrate their effects
via their respective receptors; HCRT receptor 1 and 2 and MCH
receptor 1 and 2 (8, 9). HCRT neurons project to all wake-
promoting nuclei of the brain located in the brainstem, basal
forebrain, hypothalamus, and thalamus (7). As physiological in-
tegrators they act as intermediates between different regulatory
pathways, such as the autonomic, endocrine, feeding, reward,
and stress systems (10, 11). MCH neurons are also involved in
multiple functions including sleep, especially rapid-eye move-
ment sleep (12), regulating energy balance (13), beat frequency
of ependymal cilia, and ventricular volume (14), and are asso-
ciated in controlling stress, and learning and memory (15, 16).
There is considerable evidence that sleep disorders are lined
to alteration in HCRT signaling. Narcolepsy in dogs is linked to
recessive loss-of-function mutations in HCRT receptor 2 (17).
Patients with narcolepsy with cataplexy (also called narcolepsy
type1 or NT1) have reduced or undetectable cerebrospinal fluid
levels of HCRT-1 peptide and immunostaining of postmortem
hypothalami shows no or dramatically reduced HCRT cells, while
MCH cells are intact (18). Hypocretin deficiency is accompanied
by sudden loss of muscle tone (cataplexy) and daytime sleepiness,
the 2 main features of narcolepsy with cataplexy. In addition, Hcrt
gene deletion in mice results in a phenotype similar to human
narcolepsy (19). How narcolepsy patients lose the expression of
the Hcrt gene or HCRT cells remains a mystery, but one hy-
pothesis is an autoimmune-driven destruction of HCRT cells
(20). The specific peptide expressed by HCRT cells and targeted
by the immune attack is unknown, although autoreactive T cells
to HCRT were recently reported (21) in narcolepsy with and
without cataplexy. The important role of MCH in the patho-
physiology of obesity, especially diet-induced obesity, is proven
(9, 13, 22). How these multiple functions are accomplished by a
small number of hypothalamic neuronal cell types needs careful
investigation of their intrinsic properties.
Transcriptional maps for MCH cells were lacking until very
recently (23) and attempts to obtain profiles for HCRT neurons
relied on total RNA or mRNA of HCRT cells through transcript
precipitation and comparing brains with and without HCRT (24–
27), except in the recent single-cell transcriptome study (23). For
the mRNAs obtained from HCRT neurons, some portion of
transcripts is lost due to technical problems and because transcripts
are not precipitated from purified cells. In the comparative study
between HCRT-deficient and normal brain tissues, the differen-
tially expressed genes (DEGs) can be masked by transcripts of
other cell types. Finally, microarray technology was used to
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compare the samples, which is less sensitive than RNA sequencing
(RNA-seq), a technique that allows the detection of differentially
spliced transcripts and transcripts with low abundance. In zebra-
fish, RNA-seq was used on purified HCRT cells and led to the
identification of the Kcnh4a gene, which has a sleep modulatory
role (28). Complementary to these approaches, emerging tech-
nologies, like single-cell sequencing of specific (MCH and HCRT)
(29) or whole LH cell types (23), have substantially improved our
understanding of molecular properties of these cell types in the
adult mouse brain.
We hypothesized that a specific transcriptional machinery is
responsible for the unique features of HCRT and MCH cells. To
identify molecules that orchestrate the early specification of
these cell types and to characterize molecules unique to them, we
purified these cells from the mouse brain. We identified a set of
transcription factors (TF) with important roles in the fate de-
termination of both HCRT and MCH cells. One of these, PEG3,
was identified with a substantial role in regulating vigilance states.
The result of this high-throughput study and the discovery of these
specific TFs led us to develop a protocol to derive these neuronal
populations from mouse fibroblasts, that could potentially be ap-
plied to human cells to establish an in vitro model or for cell-
replacement therapy in narcolepsy with cataplexy. Through this
process, we have also identified molecules with potential impor-
tance in understanding the pathophysiology of narcolepsy.
Result
Transcriptome Analysis of Different Brain Areas in Hcrt Gene-, or Hcrt
Cell-, Ablated Mice Reveals Qrfp as a Putative Marker of Narcolepsy
with Cataplexy. To identify cell type-specific regulators of
HCRT cells, we used 2 mouse models of narcolepsy with cata-
plexy: Hcrt gene knockout (Hcrtko/ko) mice (19) and Hcrt-ataxin-3
mice in which HCRT cells are ablated by the expression of the
ataxin-3 gene (30). We hypothesized that comparing the brain
transcriptome of these mice and their controls might identify
transcriptional changes due both to a lack of the Hcrt gene and
HCRT neurons altogether (as in narcolepsy). We dissected the
hypothalamus, brainstem, and neocortex of adult mice belonging
to 4 genotype groups: Hcrtko/ko and Hcrt+/+ littermates, and Hcrt-
Ataxin-3 hemizygous transgenic (Tg+) and WT littermates. RNA
was purified and submitted to high-throughput RNA-seq.
As expected, the Hcrt transcript was found to be severely de-
pleted in the hypothalamus of Hcrtko/ko and Hcrt-ataxin-3 trans-
genic mice (Fig. 1A). Nevertheless, very few DEGs except Hcrt
were identified (adjusted P < 0.05) (SI Appendix, Table S1).
Analysis showed that in the cortex of Hcrtko/ko mice Kcnh4 and
Krt12 gene transcripts were down-regulated by more than 2-fold.
Kcnh4 encodes a voltage-gated potassium channel proposed to
play a role in sleep regulation in zebrafish (28). In Hcrt-Ataxin-3
mice, comparing all 3 brain areas with respective controls identi-
fied the Cenpc1 gene with significant up-regulation in transgenic
animals (Fig. 1B). Cenpc1 encodes a protein that modulates DNA
methylation and the histone code at centromeric regions (31).
One of the very few genes that were affected by HCRT cell
loss in Hcrt-Ataxin-3 but not Hcrt gene deletion was Qrfp, which
attracted our attention due to its neuropeptidergic identity and
anorexigenic function. Hcrt-Ataxin-3 Tg+ mice exhibited a 50%
decrease in Qrfp transcript levels in their hypothalamus relative
to controls, while levels in Hcrtko/ko mice did not differ from WT
littermates (Fig. 1C). To confirm Hcrt-ataxin-3 Tg+ mice hypo-
thalamic Qrfp reduction, the hypothalamus was dissected at the
age of 1, 3, 6, and 9 wk, and analyzed by qRT-PCR. A massive
reduction of Hcrt gene expression during all ages was observed,
while there were no changes in Pmch gene expression (Fig. 1 D
and E). More than 50% reduction was observed in Qrfp gene
expression at all ages (1 wk: WT = 0.9 ± 0.07 vs. tg = 0.31 ± 0.05,
P < 0.01; 3 wk: WT = 2.9 ± 0.2 vs. tg = 0.9 ± 0.06, P < 0.01; 6 wk:
WT = 1.8 ± 0.1 vs. tg = 0.6 ± 0.04, P < 0.01; 9 wk: WT = 1.8 ±
0.1 vs. tg = 0.7 ± 0.06, P < 0.05; t test) (Fig. 1F). It was shown in
zebrafish and mouse that QRFP and HCRT most probably
comprise different subgroups of hypothalamic cells with no
colocalization (25, 32). Nevertheless, single-cell RNA-seq anal-
ysis of the hypothalamus indicated colocalization of Qrfp and
Hcrt and hierarchical clustering of hypothalamic neuronal sub-
types defined by unique molecular fingerprints showed Hcrt and
Qrfp among the closest neuronal subtypes, with the difference
that QRFP neurons also highly express brain-derived neuro-
trophic factor (33). Our finding that Qrfp is lost together with
HCRT neurons in Hcrt-ablated mice suggests that Qrfp might
play a role not only in the control of sleep and metabolism but
potentially in narcolepsy.
Sorting of Intact Lateral Hypothalamic Cells. Despite the discovery
of Qrfp, the above experiment suffers several shortcomings as
described in our introduction. To define the specific transcrip-
tional repertoires of HCRT and MCH neurons, we set out to
purify each cell type, and compare their transcriptomes to the
rest of hypothalamus and to each other. Cell survival rate was
too low during and after sorting of adult brains, while it was
feasible for late embryonic stages (embryonic day [E] 18 to E19).
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Fig. 1. Identification of Cenpc1 and Qrfp as putative narcolepsy gene mark-
ers. (A–C) Differential RNA sequencing analysis between Hcrtko/ko (OXKO), or
Hcrt-Ataxin-3 Tg (OXAt) mice, and their respective control littermates (Ctrl),
was performed in 3 brain regions (brainstem, cortex, and hypothalamus).
Depicted are the differential expressions of Hcrt, Cenpc1, and Qrfp in each
region. Note that Qrfp mRNA levels are about 50% reduced in the hypo-
thalamus of Hcrt-ataxin-3 transgenic mice relative to WT littermates. Read
counts has been normalized with DESeq2 package. (D–F) Expression of Hcrt,
Pmch, and Qrfp in the hypothalamus of Hcrt-Ataxin-3 transgenic and WT lit-
termates at 4 developmental time points (1, 3, 6, and 9 wk after birth). Shown
are values (mean ± SEM, arbitrary units) derived from qRT-PCR analysis (t test,
n = 3 mice; *P = 0.023; **P < 0.01; ***P < 0.001).
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We established a protocol in which the hypothalamus of E18 to
E19 Hcrt-Cre transgenic (34) or C57BL/6J mice embryos were
dissected and dissociated single hypothalamic cells were pre-
pared and transduced with viral vectors with reporter proteins
(Fig. 2A and SI Appendix, Supplementary Information Text). The
challenging issue was the purification of HCRT cells due to the
low number of cells and the low expression level of the Hcrt gene
at this developmental stage. Therefore, regular reporter markers,
like eGFP in Orexin-eGFP mice (35), are not suitable. To im-
prove the sorting, we set up a system enabling the amplification
of the reporter gene. We took advantage of an adeno-associated
virus (AAV) vector where anmCherry gene is inserted downstream
of Eef1a1 promoter in the opposite orientation between 2 loxP
sites (Fig. 2B). The neurobasal medium containing cells and viral
vector were dispensed in low adherent 96-well plates. This method
forces cells to quickly aggregate, which improves tremendously the
survival rate (Fig. 2A). Aggregates were kept in neurosphere me-
dium for 7 d to allow mCherry accumulation and cell sorting (Fig.
2C). We were able to sort 234.87 ± 126.29 mCherry+ cells from
each E18 to E19 brain and collected about more than 5,000 cells
for each biological replicate (3 replicates of mCherry+ and
3 mCherry−) (SI Appendix, Fig. S1A). A total amount of high-
quality RNA, ranging from 1 to 2.5 ng, was extracted from sam-
ples (SI Appendix, Fig. S1C) and RNA-seq was performed to
identify DEGs.
To purify the MCH cells, which show enough E18 to E19
expression level, we isolated them based on the level of EGFP
expression. To this end, we inserted the eGFP sequence between
2 long-terminal repeats of the pRRLSIN lentiviral backbone
under the mouse Pmch gene promoter and the mCherry se-
quence under the human PGK promoter (Fig. 2D). To verify if
the lentivector acts specifically, we transduced the hypothalamus,
cortex, and cortex+hippocampus cell cultures. One week later
the cultures were stained for the expression of EGFP and MCH.
Only in hypothalamic cultures was the expression and colocali-
zation of both peptides detected, indicating that our construct is
specific (Fig. 2E). MCH cells were sorted based on this lentiviral
system and approximately the same number of cells was sorted
and high-quality RNA was extracted for RNA-seq.
Identification of Enriched Genes by FACS Sorting of HCRT and MCH
Cells. As expected, RNA-seq results showed a large enrichment
of read counts for mCherry RNA in HCRT cells (mCherry+ =
67.1 ± 21.9 vs. mCherry− = 11.2 ± 1.9, counts per million reads
[cpm], mean ± SEM) and for EGFP in MCH cells (EGFP+ =
82.5 ± 2.4 vs. EGFP− = 15.6 ± 0.25, cpm, mean ± SEM) (Fig. 3 A
and B). This analysis revealed 652 DEGs, among them 350 genes
up-regulated in HCRT cells by more than 2-fold. In addition to
Hcrt, Pdyn (3-fold increase), Dlk1 (4.5-fold increase), and Adra2a
(3-fold increase) are known markers of HCRT cells (24). We
also identified 2,665 DEGs in MCH cells compared with other
hypothalamic cell types; 468 of them were up-regulated more
than 2-fold (Fig. 3 C and D and SI Appendix, Table S2). A higher
number of DEGs for MCH neurons might be due to the fact that
these neurons appear to be more mature at E18 to E19 than
HCRT neurons. In silico verification (Allen atlas) of the ex-
pression of some of these DEGs confirmed hypothalamic and
lateral hypothalamic expression patterns in the adult mouse
brain (SI Appendix, Fig. S2). We also confirmed the colocaliza-
tion of some of these genes with HCRT and MCH by immu-
nohistochemistry (Fig. 3E).
Unique Gene Sets Distinguish HCRT and MCH Cell Types. We identi-
fied 2 gene sets which might underlie the unique characteristics
of these 2 cell types: (i) a set of genes with TF and DNA bind-
ing activity, and (ii) specific genes that are part of some impor-
tant pathways and are differentially regulated between the 2
cell types.
Eighteen genes with DNA binding and TF activity were up-
regulated more than 2-fold in HCRT cells and 18 in MCH cells.
Only Ldb2 and Ahr were shared between the 2 cell types, with
the remaining TFs being cell-type specific (Fig. 4A and SI Ap-
pendix, Table S3). Lhx9, proposed as a regulator of HCRT cell
development (24, 25, 36), was not significantly changed between
cell types. Of the other Lhx gene family members, only Lhx3 and
Lhx6 were less expressed in MCH cells (SI Appendix, Table S2).
Pathway analysis for differentially regulated genes highlighted
signaling, disease, and metabolic pathways. In this analysis, we in-
cluded all significantly differentially regulated genes and identified
shared but differential pathways between the 2 cell types. The gene
list with opposite direction of expression is shown in Fig. 4B. These
genes have exosomal, hormonal, and signaling but mainly unknown
functions and have lateral hypothalamic expression. Pathway
analysis indicated that some of these genes are involved in infec-
tious diseases, autoimmune thyroid disease, mRNA surveillance,
amyotrophic lateral sclerosis, and the PI3K-Akt signaling pathway
(SI Appendix, Table S4). Opposite direction of expression of these
genes in the 2 cell types might also explain their opposite contri-
bution to behaviors, such as sleep (HCRT promoting wakefulness
and MCH sleep).
By analyzing the expression pattern of HCRT and MCH
neurons with immunohistochemistry and with the mature neuro-
nal marker NeuN (anti-NeuN antibody against purified nuclear
proteins from mouse brain), we made a serendipitous discovery.
HCRT neurons do not express the NeuN marker, while MCH
neurons and other hypothalamic neurons do (Fig. 4C). To test the
specificity of this finding we also tested another NeuN antibody
(against the first 100 amino acids of the human NeuN) and found
exactly the same lack of staining of HCRT neurons. This is sur-
prising since NeuN is expressed by all CNS mature neurons except
by Purkinje and Golgi cells of the cerebellum (37). NeuN is encoded
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Fig. 2. Methods for isolation of HCRT and MCH neurons. (A) Schematic of
the method used for the isolation of hypothalamic cells. Hcrt-Cre transgenic
mice and C57BL/6J mice were used to purify HCRT and MCH cells, re-
spectively. In this method, dissociated hypothalamic cells are dispensed in
low adherent 96-well plates inside neurosphere medium containing viral
vectors. Addition of bFGF from day 2 is helpful for survival rate. (B) AAV
construct used for purification of HCRT cells from Hcrt-Cre embryonic mice
brain. In this viral vector the expression of mCherry requires Cre recombi-
nase. (C) Cultured E18 hypothalamic cells isolated from Hcrt-Cre transgenic
mice, after transduction with AAV carrying the mCherry gene, accumulate
enough expression of mCherry within 7 d. (D) Dual reporter lentiviral con-
struct for the purification of MCH cells. (E) Embryonic cultures of hypo-
thalamus (Hypo), cortex (Cx) and cortex and hippocampus (Cx+Hipp) were
transduced with dual reporter lentiviral vector. After 7 d, MCH and EGFP are
only detected in the hypothalamus where MCH cells belong. (Scale bars: 50 μm.)
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by Rbfox3 (38), a splicing regulator, suggesting that adult HCRT
neurons might have a set of differentially spliced mRNAs.
Several ion channels and receptors were also identified for
each cell type (SI Appendix, Fig. S3). Finally, we detected a
strong up-regulation of the Trhr gene in HCRT cells and it is
known that thyrotropin-releasing hormone (TRH) stimulates
these neurons (39) (SI Appendix, Table S2).
Morpholino Knockdown of Candidate TFs. To identify a possible
role of the candidate TFs to modulate Hcrt and Pmch gene ex-
pression, we knocked down their expression by morpholino oli-
gonucleotides (Mo) (SI Appendix, Supplementary Information
Text and Table S7) in zebrafish embryos at the 1-cell stage.
Among candidate TFs, PEG3 is not found in the zebrafish ge-
nome. We therefore used its ortholog in Danio rerio (si:ch211-
266d19.4; XM_009297216.2; zinc finger protein 271, Zfp271).
Among 10 top TFs enriched in HCRT cells, Mo-Zfp271 at 2.5 ng
strikingly abolishedHcrt gene expression (Fig. 5 A and B) but did not
result in an any developmental defect (Fig. 5A and SI Appendix, Fig.
S4A). Mo-Six6 (33%) and Mo-Prrx1 (10%) at 1.25 ng also reduced
Hcrt expression. At 2.5 ng, Mo-Six6 (45%) and Mo-Prrx1(38%) had
the most pronounced effect after Mo-Zfp271(100%), Mo-Ahr
(57%), and Mo-Nr2f2 (40%), indicating that HCRT cells might
arise from the Six family-expressing domain of the embryonic
hypothalamus (40). The phenotype obtained from knockdown of
several TFs enriched in MCH cells was partial loss of MCH signal
for Mo-Gbx2, Mo-Lmx1a, and Mo-Msx2a (50%, 60%, and 22%
respectively) (SI Appendix, Fig. S4B). Peg3 was not enriched in
MCH neurons but to test if it has any effect on Pmch expression,
we also injected Mo-Zfp271 and surprisingly observed that it also
totally abolished MCH expression (SI Appendix, Fig. S4B).
Altered Locomotor Activity and Sleep Architecture in Zfp271 (Peg3
Ortholog) Knocked-Down Zebrafish. Enrichment of Peg3 in HCRT
cells and its effect on the expression of HCRT and MCH neu-
ropeptides suggested a potential involvement in sleep regulation.
The effect of Zfp271 knockdown on zebrafish behavior was
assessed using a locomotor activity assay, as previously described
(41, 42). Mo-Zfp271 larvae exhibited significantly less locomotor
activity mainly during daytime (day 1: WT = 42.6 ± 5.8 vs. Mo-
Zfp271 = 21.1 ± 2.7; P < 0.01, t test) (Fig. 5C). This reduction in
activity is accompanied with 2-fold increase in sleep time during
the day (day 1: WT = 24.2 ± 2.6 vs. Mo-Zfp271 = 45.2 ± 1.5; day
2: WT = 28 ± 2.2 vs. Mo-Zfp271 = 41.6 ± 1.4; P < 0.0001, t test)
(Fig. 5D). Analysis of sleep bout number and duration showed
that the increase in sleep amount is mainly due to increased bout
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opposite direction of expression between HCRT (green) and MCH (red) cell types. The graph shows fold-change in gene expression when HCRT and MCH cells’
transcriptome are compared with the rest of the hypothalamus. (C) Immunostaining for colocalization of hypothalamic HCRT and MCH cells with NeuN
neuronal marker. As shown MCH as many other surrounding cells express NeuN while HCRT cells do not. (Scale bars: 20 μm.)
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duration both during the light (day 1: WT = 0.3 ± 0.02 vs. Mo-
Zfp271 = 3.4 ± 1.3; P = 0.025, t test) and the dark period (night
1: WT = 9.5 ± 1.3 vs. Mo-Zfp271 = 20.9 ± 2.5, P < 0.0001; night
2: WT = 5.2 ± 0.6 vs. Mo-Zfp271 = 9.3 ± 2, P = 0.05, t test)
(Fig. 5E).
Peg3 Loss-of-Function in Mice Reduces the Number of HCRT and MCH
Cells. Peg3 is expressed from the paternal allele and female mice
inheriting a targeted deletion of this allele display striking im-
pairment of maternal behavior and decreased number of oxy-
tocin neurons (43). In the same model system, we found a
16.31% decrease in the number of HCRT cells (WT [n =
5]:1716.4 ± 95.7 vs. KO [n = 6]: 1436.5 ± 66.39, mean ± SEM,
P = 0.04, Mann–Whitney U test) and a 15.44% reduction in
MCH cell number (WT [n = 5]: 3307.4 ± 123.6 vs. KO [n = 6]:
2796.5 ± 154.2, mean ± SEM, P = 0.02, Mann–Whitney U test)
(Fig. 5F). These significant reductions confirmed a role for Peg3
in regulating these critically important cell types.
We also investigated Peg3 gene-expression levels in mice at
different postnatal time points. The results showed that at post-
natal day 21, when Hcrt and Pmch reach the peak of expression,
Peg3 also reaches its maximum level, indicating a strong temporal
expression relationship between the 3 genes (Fig. 5G).
Transcriptome Data as a Roadmap to Generate MCH and HCRT Cells
from Mouse Induced Pluripotent Stem Cells. To further understand
the development of HCRT and MCH neurons, we aimed at
establishing these neuronal cell types from pluripotent stem
cells. We first focused on the generation of HCRT cells to
monitor them easily in culture; we established induced pluripo-
tent stem cells (iPSCs) from skin fibroblast of Hcrt-eGFP mice.
This was performed by introducing 4 TFs (OCT3/4, SOX2,
c-MYC, and KLF4) in fibroblasts and after 2 wk embryonic stem
cell-like colonies were picked up and expanded. The colonies
expressed known pluripotency markers (SI Appendix, Fig. S5 A
and C) and silenced their transgenes, which normally should
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Fig. 5. Knockdown of critical TFs identified for Hcrt
and Pmch gene expression and sleep behavior in fish.
(A, Left) Mortality and developmental defect rate of
48-h postfertiliation zebrafish larvae injected with
2.5 ng of candidate Mo (SI Appendix, Table S7). Data
are presented as percentage of fish that exhibit the
phenotype (10 < n < 20). (Right) Visualization of
HCRT signal in brain hemispheres of zebrafish em-
bryos by immunostaining and confocal microscopy.
The percentage of brain hemispheres positive or
negative for HCRT signal for each candidate Mo is
presented. (B) Representative image of loss of HCRT
signal in Mo-Zfp271-injected zebrafish brains com-
pared with controls. (10× confocal magnification.)
(C) Hourly distribution of locomotor activity of
Zfp271 morphants and their respective controls
during 48 h (night [10 h] and day [14 h]). Dark pe-
riods are indicated in gray and light periods in white.
As shown in the bar graph (Right) Mo-Zfp271-
injected zebrafish exhibit about 50% reduced loco-
motor activity during the light period. **P < 0.01;
***P < 0.001. (D) Hourly distribution of sleep during
48 h. Mo-Zfp271-injected zebrafish exhibit profound
increase in sleep time compared with controls. (E)
Sleep bout numbers and bout durations in Mo-
Zfp271-injected fish compared with controls. During
both light and dark periods, Zfp271 morphants ex-
hibit reduced bout number. *P < 0.05; ***P < 0.001;
n = 48, mean ± SEM, t test. (F) HCRT and MCH neu-
ron counts in Peg3 hemizygous KO mice (Hz; Peg3+/−)
and their WT littermates. The entire hypothalamus
was covered from anterior to posterior regions and
all sections were counted. *P = 0.04 for HCRT and
*P = 0.02 for MCH; total cell number ± SEM, Mann–
Whitney U test; n = 5 to 6. (G) Quantitative PCR of
brain Hcrt, Pmch, and Peg3 expression during dif-
ferent time points. There is a parallel increase in the
expression of Hcrt and Pmch along with Peg3 up to
3 wk after birth. *P = 0.019 for Peg3 and P = 0.03 for
Pmch; **P < 0.01; n = 3, mean ± SEM; t test. (H)
Potential gene network for identified TFs within
HCRT cells. Their interactions are extracted from
databases. The more effective TFs in zebrafish study
(green) have bigger sizes. Identified TFs but not
tested are in brown and potential targets in red.
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occur after activation of internal stemness genes (SI Appendix,
Fig. S5B). The established iPSCs also had strong potential to
differentiate toward neural lineage (SI Appendix, Fig. S5D).
To differentiate our iPSCs toward hypothalamic neuronal
progenitors, we took advantage of a protocol established byWataya
et al. (44). This method applies a strictly chemically defined me-
dium with minimum level of inductive signals called “growth factor-
free chemically defined medium” together with quick aggregation
where the seeded cells are quickly precipitated in wells of low-
adherent 96-well plates. Preliminary screening using this protocol
with different conditions (more than 100 conditions) failed to in-
duce Hcrt and Pmch gene expression (SI Appendix, Fig. S5E). Next,
we tested if any specific signaling molecule can induce the ex-
pression of some TFs enriched in HCRT (Peg3, Prrx1, and Six6)
and MCH (Msx2, Lmx1a, and Rfx2) cells from our RNA-seq ex-
periment. To this end and based on the days that hypothalamic
(Rax gene) and neuroepitelial (Sox1 gene) markers start to be up-
regulated during neuronal differentiation (Fig. 6A), we changed the
protocol and from day 4 applied different signaling molecules and
growth factors individually (SI Appendix, Fig. S5F). Screening of
several molecules identified BMP7 as a highly potent molecule to
induce the expression of TFs of interest (Fig. 6B). Almost all 6 TFs
that were tested were strongly expressed in BMP7-treated cells
(Fig. 6B). Intriguingly, BMP7 induced the expression of Pmch but
not Hcrt gene (Fig. 6 B–D).
We next performed a detailed analysis of the effect of
BMP7 on Pmch expression. Exposure of the neurospheres from
day 4 showed that BMP7 exerts its effect 2 d after addition and
Pmch expression is increased during several days (Fig. 6C). The
effect of BMP7 was more pronounced only from day 4 (SI Ap-
pendix, Fig. S6A) and was dose-dependent (Fig. 6E and SI Ap-
pendix, Fig. S6D). Sonic hedgehog, which is one of the major
regulators of hypothalamic patterning (45), was not able to in-
duce Pmch expression, either in different media or at different
concentrations (SI Appendix, Fig. S6D). The effect of the other
members of BMP family, BMP4, was not as strong as BMP7 (SI
Appendix, Fig. S6B). Addition of the retinoic acid, which is the
important player for caudal CNS patterning (46), suppressed
Pmch expression (SI Appendix, Fig. S6C). After 2 wk, the neu-
rospheres were dissociated and cultured on coated dishes for
2 extra weeks to allow mature neuronal growth. Staining for
MCH and MAP2 showed that MCH-expressing cells also express
MAP2, indicating that these cells are mature neurons (Fig. 6F).
We tested if any specific combination of TFs other than MCH
cell-specific TFs, are affected by BMP7, which results in the in-
duction of Pmch gene expression. qPCR analysis of about
30 candidate genes showed that, while genes from the Pax family
are strongly down-regulated under BMP7 condition, Rax, an
important hypothalamic marker, is highly expressed. Six1 also
showed increased expression. Foxg1, a major marker of telen-
cephalon development, was strongly suppressed as expected (Fig.
6G). Based on our data and the literature, we propose a model
to explain how different combinations of TFs might interact with
each other and how their up- or down-regulation induces Pmch
expression (Fig. 6H).
All above-mentioned approaches failed to induce any expres-
sion of HCRT, even though the treatment with BMP7 induced
HCRT-enriched TFs (SIX6, PEG3, and PRRX1). We performed
another large screen of molecules (SI Appendix, Fig. S6E and
Table S5) and included vitamin C as one of the treatments. The
reason for the inclusion of vitamin C was the enrichment of the
Gulo (L-gulonolactone oxidase) gene in our HCRT cell RNA-seq
experiment as well as our RNA-seq of Hcrt-ataxin-3 mice (SI
Appendix, Fig. S6F). L-Gulonolactone oxidase is the enzyme pro-
ducing the precursor to ascorbic acid (47). Although a few of the
screened molecules induced HCRT expression, only vitamin C
treatment could be reproduced (SI Appendix, Fig. S6G). Inclusion
of vitamin C in combination with different molecules showed its
potential to induce the expression of the Hcrt gene (Fig. 6I). Vita-
min C displays almost the same effect as ManNac, which has pre-
viously been shown to also induce the expression of Hcrt gene (48).
After plating the cells in poly-D-lysine (PDL)–coated dishes,
EGFP-expressing neurons derived from Hcrt-EGFP iPSCs were
detected in our cultures (Fig. 6J). To test if our in vitro MCH and
HCRT cells are functional, we measured the secretion of their
respective neuropeptide in the cell culture medium. MCH and
HCRT cells plated on PDL dishes for 2 wk secreted about
96.61 ± 9.87 and 6.14 ± 1 pg/mL of their neuropeptides, re-
spectively (Fig. 6K). After stimulation with an inducer molecule
(TRH [125 nM] for HCRT cells and HCRT-1 [1 μM] for MCH
cells), the levels increased to 115.35 ± 8.84 and 8.63 ± 0.38 pg/mL.
Maturation stage also affects their functionality and more
mature neurons showed more secretion of MCH (3-wk culture:
174.03 ± 31.67 vs. 2-wk culture: 96.61 ± 9.87 pg/mL) and HCRT
(3-wk culture: 8.68 ± 2.3 vs. 2-wk culture: 6.14 ± 1 pg/mL,
mean ± SEM, n = 3) neuropeptides (Fig. 6K).
Network of TFs in HCRT and MCH Cells. Partial or complete effect of
the removal of a TF depends on the gene network. Based on the
literature and different databases (BioGRID, TRRUST, and
STRING), we predicted a potential network for the 18 identified
TFs and their targets (physical and genetic interaction) in
HCRT cells, which might explain the results of our knockdown
experiment in zebrafish. PEG3 has the largest weight on the
network since its removal totally abolishes HCRT expression
(Fig. 5H). Ldb2, which showed no effect on the expression of the
Hcrt gene when knocked down, has a direct interaction with the
LHX protein family, which was shown to be necessary for a
subset of HCRT neurons (24) (Fig. 5H). To have a broader view
and to gain insight into how these cell types exert their multiple
functions, we created a map of TFs to understand how different
TFs assigned to different functions, like sleep or feeding, interact
with each other. To this end, we used only experimentally avail-
able data in which these TFs were shown to display either physical
or genetic interaction. The pool of TFs was chosen based on the
following 3 criteria: (i) TFs up-regulated in our RNA-seq data, (ii)
TFs regulating genes up-regulated more than 2-fold, and (iii) TFs
with known functions in a specific behavior, such as FOXA2 (49)
in feeding and LHX9 (24) and EBF2 (50) in sleep. For all TFs we
also extracted if they have a salient role in a specific phenotype
and if they are part of a specific pathway. Some TFs participated
in known functions, such as development, sleep, and feeding be-
havior and obesity in both HCRT and MCH cells (SI Appendix,
Fig. S7). Not only are there shared TFs between different func-
tional groups, but they also interact with each other. Normally the
output of this gene network is the expression or inhibition of Hcrt,
Pdyn (Dynorphin), and glutamate for HCRT cells and the ex-
pression or inhibition of Pmch and Gaba for MCH cells, and
proper functioning of these cell types (SI Appendix, Fig. S7). If
these outputs are altered under different physiological and path-
ological conditions, it requires alteration in the gene network, as
well. No TF can be excluded from any function but the figure
presented here (SI Appendix, Fig. S7), which is based on available
data, depicts some specifications. For example, the involvement of
FOXA2 in feeding behavior might require different connections
within the 2 cell types (SI Appendix, Fig. S7). One more layer was
also added to this map to indicate the pathways in which the TFs
are involved (SI Appendix, Table S6).
Discussion
Using the end-stage markers of lateral hypothalamic neurons,
which are neuropeptides HCRT and MCH, we established their
transcriptional machinery. To our knowledge this study is unique
in purifying intact HCRT and MCH cells from late embryonic
brains of mice. We identified molecules that might be the driving
machinery of these neurons and used these markers as a guideline
to develop protocols to establish these cells from mouse iPSCs.
Our aims were to establish a method to dissociate and culture
live neurons and to have a specific marker to isolate specific cell
types. With reporter proteins under specific promoters and quick
aggregation method, it was possible to specifically purify them.
Nevertheless, in the case of cell types with weak expression of
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their specific markers the amplification of the reporter gene is
required for which our developed method is of high efficiency.
We showed that the development of an intact hypocretin sys-
tem requires PEG3, AHR, NR2F2, SIX6, PRRX1, and NKX6-2 as
TFs, and that of the MCH system requires MSX2, GBX2,
LMX1A, RFX2, SIX1, RAX, as well as PEG3. The respective role
of these transcriptional factors in the development of HCRT and
MCH needs further investigations by loss-of-function experiments
in mice. Recently, in a comprehensive study by using single-cell
sequencing (23), the molecular signatures of HCRT and MCH
neurons in the adult mouse brain were identified, which can be
complementary to our embryonic findings in constructing an
overall transcriptional blueprint for these cell types. Although due
to the developmental age differences we do not expect identical
findings between these 2 studies, we did find important genes and
TFs shared between the 2 for HCRT cells (Slc17a6, Pdyn, Scg2,
Rasgrp1, and Plagl1). Interestingly, PLAGL1, which was recently
reported to have a role in Hcrt transcription (51), is enriched in
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Fig. 6. Generation of HCRT and MCH neurons from
iPSCs. (A) qRT-PCR for pluripotency (Oct3/4, Nanog),
hypothalamic (Rax), and early neuroepithelial (Sox1)
markers. A large decrease is observed in the expres-
sion level of pluripotent markers within 4 d while
hypothalamic genes exhibit marked increase. (B, Up-
per) Schematic figure, which indicates that induction
of candidate genes enriched in HCRT and MCH cells,
with the help of a specific molecule or condition(?),
might induce the expression of Hcrt and Pmch genes.
(Lower) RT-PCR for TFs enriched in HCRT andMCH cells
in cultures exposed to different signaling molecules
and growth factors. iPSCs using protocol in SI Appen-
dix, Fig. S5F were exposed to different molecules with
potential role in the hypothalamus development.
BMP7 showed strong potential to induce all indicated
TFs and also Pmch. (C) The expression pattern of Pmch
in the samples with and without BMP7 after different
days in culture. Differentiating neurospheres were
treated with and without 10 ng/mL BMP7 from day 4.
Only in BMP7-treated samples a large expression of
Pmch was observed and not in controls. (D) qRT-PCR
for Pmch expression. Samples were treated as in C. (E)
The effect of different concentrations of BMP7 on
expression pattern of Pmch. Results show that the
effect of BMP7 on the expression of Pmch is dose-
dependent. (F) Neurospheres were kept in differenti-
ation medium for 12 to 14 d before being dissociated
and plated on PDL-coated dishes to produce mature
neurons. Two weeks after plating the cells were
stained for MCH and MAP2 expression. (G) qRT-PCR
for representative genes among 30 tested genes
downstream of Bmp7. (H) Schematic model of how TFs
interact with each other to induce Pmch expression.
For details see Discussion. (I) qRT-PCR for Hcrt expres-
sion under different differentiation conditions. The
same method as for MCH differentiation was used to
drive Hcrt expression except that ascorbic acid was
used instead of BMP7 from day 3. Ascorbic acid in-
duced Hcrt expression alone and in combination with
other tested molecules (SI Appendix, Table S5). Due to
short RNA sequence of the Hcrt gene, 2 different
primer sets were used. (J) Hcrt-eGFP iPSC-derived,
ascorbic acid-treated hypothalamic cells were stained
for EGFP and MAP2 expression. (K) Two weeks after
plating the neurospheres, differentiated HCRT and
MCH cells were stimulated with TRH for HCRT and
HCRT-1 for MCH cells for 3 h and the medium were
collected to measure secreted molecules in the me-
dium. Bar graphs show ELISA results for secretion
analysis of HCRT and MCH neuropeptides. *P =
0.04 for HCRT and P = 0.039 for MCH; **P < 0.01; n =
3, mean± SEM, t test. ForD, E,G, and K: *P < 0.05; **P<
0.01. Scale bars: F and J, Left, 50 μm; J, Right, 10 μm.)
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both datasets, suggesting that this TF is substantially expressed
from embryonic stage until adulthood and might be involved in
controlling the Hcrt expression. We established the transcriptional
machinery for these 2 cell types and illustrated the interaction of
TFs with each other. The identified networks shed light on how
these cell types might use their machinery during normal devel-
opment and adult functioning. These networks might also explain
how these cells integrate diverse inputs and function properly on
demand. We subgrouped TFs for development, sleep, and feeding
behavior and showed how they might interact with each other. The
important role of LHX9 and EBF2 both in development and sleep
are documented (24, 50), and we add here PEG3, which displayed
a critical role in development and sleep. The precise fine-tuning of
these networks during day and night guaranties the proper func-
tioning of these cells that otherwise may lead to sleep disruption,
obesity, and metabolic disorders.
Loss-of-function studies confirm the importance of our find-
ings at the developmental level, indicating that the TFs found
here are required for proper development of these cell types.
Removal of the Peg3 ortholog (Zfp271) totally abolished HCRT
and MCH expression in zebrafish and deletion of the paternal
allele of Peg3 significantly decreased the number of HCRT and
MCH neurons in mice. Note that Zfp271 is an ortholog of Peg3
and shares similarities to several other zinc finger proteins.
Therefore, Zfp271 in zebrafish may not be functionally identical
to Peg3 in mice. Additionally, the Zfp271-related sleep pheno-
type seen in zebrafish might be different in mice. We showed that
knockdown of Zfp271 affects locomotor activity in zebrafish;
however, in mice it might affect other aspects of sleep, such as
sleep fragmentation and the sleep EEG and not its total amount,
as shown in HcrtKO/KO mice. Such species differences need fur-
ther investigation. Peg3 is an imprinted gene with close connec-
tivity to Zim1 (52). It was established that the Magel2 imprinted
gene, which is similar to Peg3, a paternally expressed gene, also
regulates Hcrt expression (53). Peg3 has sex- and tissue-specific
promoters (54) and is believed, like many other imprinted genes,
to have a monoallelic pattern of expression, although it was
shown recently that in some regions of the brain, specifically in
the hypothalamus, there is a biallelic pattern of expression (55).
Our finding that the deletion of the paternal allele significantly
decreases but does not abolish the expression of HCRT and
MCH suggests that some compensation mechanisms, including a
role for the maternal allele, are at play. Furthermore, Peg3 might
play a role in the early development of HCRT and MCH neurons
and not at the adult stage. How HCRT and MCH systems depend
on imprinted genes and whether Peg3 also depends on the core
clock machinery remain to be discovered. The involvement of
Peg3 in the modulation of sleep in zebrafish seems dependent on
its effect on Hcrt and Mch expression, but whether HCRT and
MCH are the only affected cell types and whether both sexes are
affected at the same level remains to be investigated, as it was
shown that hypothalamic oxytocin neurons and maternal behavior
are affected in Peg3 female KO mice (43). Peg3 in association with
Traf2 is involved in the TNF–NF-κB signal transduction pathway,
which leads to cell survival or death (56). Therefore, it can be
speculated that in some pathological conditions, such as in nar-
colepsy where HCRT neurons seem to be selectively destroyed,
Peg3 can participate in HCRT cell death.
The difficulties in accessing intact neurons from the human
brain prompted us to establish protocols to produce these cells
from iPSCs. We established iPSCs from mouse fibroblasts and
differentiated them toward lateral hypothalamic cell types. We
identified BMP7 as the master signaling molecule that regulates
the main TFs of both cell types and the expression of Pmch.
RNA-seq of MCH cells indicated that GBX2 is a TF up-
regulated in these cells. Gbx2 expression highly influences the
expression of Pax2 (57, 58), which itself is suppressed by BMP7
(Fig. 6G). Six1, which is also up-regulated by BMP7 treatment
(Fig. 6G), has strong genetic interaction with Pax2 (59). On the
other hand, MSX2, which is the TF with the highest (5.5-fold
change) overexpression in MCH cells, is highly expressed under
BMP7 exposure (Fig. 6B). Based on these findings we propose a
model for the generation of MCH cells from stem cells (Fig. 6H).
This model suggests BMP7 as the major player in fate de-
termination of MCH cells.
To induce the expression of the HCRT gene we applied vitamin
C, of which its role in CNS development is well-documented. It was
shown in the fetal rat brain that vitamin C increases from 374 μg/g
on the 15th day of gestation to 710 μg/g by the 20th day and re-
mains at this level until birth (60). Our findings are complementary
and add induction markers to the other studies that successfully
generated hypothalamic cells from human and mouse stem and
iPSCs (48, 61–63). Since we derived HCRT neurons from Hcrt-
EGFP mice expressing eGFP under the control of a 3.4-kb human
Hcrt promoter (64), the generated cells may not be identical to the
authentic mouse HCRT neurons. However, we believe that the
authentic promoter is also activated as we reported the expression
of Hcrt at mRNA and protein levels.
We identified genes and molecules which might have a role in
the pathophysiology of narcolepsy with cataplexy. QRFP is the
latest hypothalamic neuropeptide identified and implicated in
feeding, locomotor activity, arousal, and metabolism (65–67).
More recently QRFP and its receptor GPR103 were found to
regulate sleep in zebrafish (42). Additionally, the QRFP receptor
GPR103 heterodimerizes with HCRT receptors and is involved
in protection against Alzheimer’s disease (68). QRFP seems not
to be colocalized with HCRT, suggesting that its reduced ex-
pression in Hcrt-Ataxin-3 mice is secondary to the lack of
HCRT cells. Since the expression of Qrfp is normal in HcrtKO/KO
mice, we speculate that its expression is under the control of
other factors produced by HCRT neurons. A secondary re-
duction of QRFP in narcolepsy, if confirmed, may explain aux-
iliary symptoms, such as food intake behavior and obesity (30,
69). The fact that the identified TFs here are also highly enriched
in the immune system suggests that more investigation on their
role in the pathophysiology of narcolepsy with cataplexy is
warranted.
Methods
Animals. Two mouse models of narcolepsy [Hcrtko/ko: B6.129S6-Hcrttm1Ywa/J
and Hcrt-ataxin-3: B6;D2-Tg(HCRT-Ataxin-3)] were used to perform RNA
sequencing of the different brain regions. Hcrt-Cre [B6;D2-Tg(HCRT-Cre-
IRES-eGFP)] mice were used to purify HCRT cells and WT C57BL/6J mice
were used for purification of MCH cells. Hcrt-EGFP (B6;D2-Tg(HCRT-eGFP))
mice were used to establish iPSCs. Peg3 KO (129Sv.MF1-Peg3Tm1) mice were
used for HCRT and MCH staining and counting. All animals were back-crossed
to C57BL/6J for at least 10 generations and provided by international collab-
orators, except for C57BL/6J mice, which were purchased from Charles Rivers
Laboratory. Animals were maintained under standard animal housing condi-
tions with free access to food and water. All experimental protocols were
approved by the Veterinary Ethical commission of the state of Vaud,
Switzerland.
RNA Sequencing. Transcriptome analysis from mouse models of narcolepsy
were performed as described in Nikolaeva et al. (70) and aligned againstMus
musculus GRCm38.75. The R package DESEQ2 was used for statistical tests.
For sorted hypothalamic cells, double-stranded cDNA for RNA-seq library
preparation was generated using SMART-Seq v4 Ultra Low Input RNA re-
agents (Catalog no. 634888, Clontech) according to the protocol provided
with the reagents beginning with 2 ng (MCH cells) or 0.8 ng (for HCRT cells)
of total RNA and using 11 cycles of PCR amplification. Next, 150 pg of the
resulting cDNA were used for library preparation with the Illumina Nextera
XT DNA Library reagents (Catalog no. 15032354, Illumina) using the single-
cell RNA-seq library preparation protocol developed for the Fluidigm C1
(Fluidigm). Data analysis is summarized in SI Appendix, Supplementary
Information Text.
Behavioral Assays. Sleep and activity of zebrafish were assessed based on refs.
41 and 42. Briefly, the behavioral tests were performed on zebrafish injected
with 2.5 ng of Zfp271-Mo, or with H2O as control. From 110 to 158 h post-
fertilization, larval zebrafish were placed into a 96-well plate, 1 per well, in
300 μL of E3 embryo medium. Locomotor activity was analyzed by the video
tracking module of the classic version of Zebrabox (Viewpoint Lifescience).
The system applied a continuous infrared detection under a 14/10-h cycle of
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light/dark. The quantification mode of Zebrabox was set up following the
parameters described in Chen et al. (42): integration time bins, 1 min; de-
tection threshold, 15; burst, 29; freeze, 3. Any 1-min epoch with less than
0.1 s of movement was considered as 1 min of sleep (42). Finally, a sleep bout
was defined as a continuous string of sleep minutes. Data were processed
using MATLAB.
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